Due to the ability of coronaviruses to bind to the angiotensin‐converting enzyme 2 (ACE2) receptors expressed in metabolic organs, it is plausible that early hyperglycaemia in COVID‐19+ patients could be related to the disease course itself.21 Here, ACE2 is linked to Hyperglycemia.